Melanoma Molecular Maps Projects


The IPD is a multicenter database, which gathers anonymized information about clinical and histopathological features as well as availability of biological material regarding patients with cutaneous melanoma enrolled by centers that participate in this project.
A systematic collection of the scientific knowledge regarding the development of targeted therapy for melanoma. Since data are gathered in a computationally compatible fashion, the database can be utilized for the identification of prevalent therapeutic hypotheses based on the available evidence and for ranking treatments based on the patient's molecular profile (drug ranking system).
Inspired to the principles of functional interactomics, this is a collection of schematic figures depicting the molecular pathways involved in cancer development and progression, with particular regard to melanoma. A close-to-hand visual guide to navigate in the ever-growing complexity of cancer molecular biology.

Search the site

Risk Assessment Tools

TNM Staging System | Total Dermoscopy Score | Thin Melanoma Prognosis |

Melanoma News

A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival.
Stenehjem JS, Grimsrud TK, Rees JR, Vos L, Babigumira R, Veierød MB, Robsahm TE
BMJ Open. 2017 Jun 21;7(6):e014829.
PMID: 28637727 [PubMed - in process]

Primary tumor sites in relation to ultraviolet radiation exposure and skin visibility correlate with survival in cutaneous melanoma.
Gordon D, Hansson J, Eloranta S, Gordon M, Gillgren P, Smedby KE
Int J Cancer. 2017 Jun 20;():.
PMID: 28635084 [PubMed - as supplied by publisher]

Impact of a 31-gene Expression Profiling Test for Cutaneous Melanoma on Dermatologists' Clinical Management Decisions.
Farberg AS, Glazer AM, White R, Rigel DS
J Drugs Dermatol. 2017 May 1;16(5):428-431.
PMID: 28628677 [PubMed - in process]

[The Mosan Study Group of Pigmented Tumours facing toward the oligometastatic cutaneous melanoma].
Piérard GE, Piérard-Franchimont C, Delvenne P
Rev Med Liege. 2017 Jun;72(6):308-311.
PMID: 28628288 [PubMed - in process]

PLK-1 Immunoreactivity is Associated with Metastases in Cutaneous Melanoma.
Kaczorowski M, Borowiec T, Donizy P, Pagacz K, Fendler W, Lipinski A, Halon A, Matkowski R
J Cutan Pathol. 2017 Jun 19;():.
PMID: 28626898 [PubMed - as supplied by publisher]

NCBI's Disclaimer and Copyright notice